This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
H

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harry Yoon
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harry Yoon
0 views
June 6, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

2024 ASCO® Annual Meeting Insights Hub: GI Videos

12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
11:57
COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…

Feat. M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner
View All

Recommended

AUTOPLAY
09:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
09:58
Elizabeth Smyth

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Feat. R. Sundar
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott
06:39
Oncology Data Advisor

Additional Advances in Esophagogastric Cancer Research and Clinical …

Feat. J. Ajani
41:38
Dana-Farber Cancer Institute

Let Me Eat: The Road to Reconstructing the Esophagus

Feat. J. Wee
15:47
Integrity CE

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Feat. K. Bever, R. Voong, J. Hernandez, S. Klempner
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
23:56
Scripps Health

Targeted Therapy Approaches for Upper GI Cancer

Feat. M. Strickland
11:57
COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…

Feat. M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner
57:57
Hope for Stomach Cancer

1L Therapy for HER2+ Stage 4 Gastroesophageal Cancers

Feat. D. Catenacci
19:29
Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue
44:18
Debbie's Dream Foundation

ASCO® 2023 Insights: "What's New in Stomach and Esophageal…

Feat. S. Klempner
23:39
OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancers

Feat. S. Gill